AIDS patients face risk for esophageal, stomach cancers

September 24, 2012

People with AIDS are at increased risk for developing esophageal and stomach carcinoma as well as non-Hodgkin lymphomas (NHLs), according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.

"People diagnosed with AIDS are living longer due to improved therapies. However, they remain at increased risk of developing a number of different cancers," said E. Christina Persson, PhD, of the and lead author of this study. "An elevated risk of esophageal and stomach cancers had been observed before, but we were able to look at risk for subtypes of these malignancies."

In this study, researchers analyzed data from the HIV/AIDS Cancer Match Study, which links data collected from 1980 to 2007 for 16 U.S. population-based HIV and AIDS and cancer registries. They compared risks of stomach and esophageal cancers in 596,955 people with AIDS with those of the general population.

Those with AIDS had a 69 percent and 44 percent increased risk of esophageal and stomach carcinomas, respectively. The risks of NHLs—tumors of —in the stomach and esophagus were also strongly elevated. Additionally, the researchers' analysis showed a significant 53 percent increased risk of cancer of the lower stomach in people with AIDS. Since Helicobacter pylori infection is one of the causes of this type of , one explanation for an increased risk of this cancer might be an increased prevalence of H. pylori in people with AIDS.

Another explanation for this elevated could be more frequent use of tobacco and alcohol among people with AIDS. Programs encouraging and alcohol moderation may help reduce the occurrence of esophageal and stomach carcinomas among these patients.

Explore further: Cancer burden shifts for people with HIV/AIDS

Related Stories

Cancer burden shifts for people with HIV/AIDS

April 11, 2011
The number of cancers and the types of cancers among people living with AIDS in the U.S. have changed dramatically during the 15-year period from 1991-2005, according to an article published online April 11th in the Journal ...

Reduce esophageal cancer danger by knowing risk factors

August 7, 2012
(Medical Xpress) -- As the American obesity epidemic has increased the past two decades, so has the rate of esophageal cancers. Clinician-scientists affiliated with the University of Cincinnati (UC) Cancer Institute say enhanced ...

Recommended for you

New strategy for unleashing cancer-fighting power of p53 gene

December 13, 2017
Tumor protein p53 is one of the most critical determinants of the fate of cancer cells, as it can determine whether a cell lives or dies in response to stress. In a new study published today in the journal Nature Communications, ...

Researchers develop test that can diagnose two cancer types

December 12, 2017
A blood test using infrared spectroscopy can be used to diagnose two types of cancer, lymphoma and melanoma, according to a study led by Georgia State University.

Cancer-causing mutation suppresses immune system around tumours

December 12, 2017
Mutations in 'Ras' genes, which drive 25% of human cancers by causing tumour cells to grow, multiply and spread, can also protect cancer cells from the immune system, finds a new study from the Francis Crick Institute and ...

Atoh1, a potential Achilles' heel of Sonic Hedgehog medulloblastoma

December 12, 2017
Medulloblastoma is the most common type of solid brain tumor in children. Current treatments offer limited success and may leave patients with severe neurological side effects, including psychiatric disorders, growth retardation ...

Drug suppresses spread of breast cancer caused by stem-like cells

December 12, 2017
Rare stem-like tumor cells play a critical role in the spread of breast cancer, but a vulnerability in the pathway that powers them offers a strategy to target these cells using existing drugs before metastatic disease occurs, ...

MRI scans predict patients' ability to fight the spread of cancer

December 12, 2017
A simple, non-invasive procedure that can indicate how long patients with cancer that has spread to the brain might survive and whether they are likely to respond to immunotherapy has been developed by researchers in Liverpool.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.